Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.
Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...
ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced the first commercial cases in the United ...
A groundbreaking prostate treatment offering life-changing relief for men has reached Far North Queensland, transforming ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
WHITEVILLE – Columbus Regional Healthcare System announced that it is among the first in our region to offer Aquablation® therapy with the new HYDROS™ Robotic System, the next-generation platform to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results